Feb 8, 2026. T-CURX invited to present at the 4th Dubai Stem Cell congress 2026

T-CURX has been invited to present about clinical advances of in vivo CAR-T therapies at the 2026 Dubai Stem Cell Congress in Dubai, UAE, and to sign MoU for a strategic partnership with FSG-Lab, Dubai

The 4th international Dubai Stem Cell Congress 2026 was hosting 400 international delegates and key opinion leaders in the field of cell therapies from Europe, Asia, North America and the Middle Esat region. Ulf Grawunder, CEO of T-CURX was invited to a presentation about recent clinical advances for in vivo CAR-T therapies. At the Opening Ceremony of the event, The CEOs of T-CURX and the First Stem Cell and Genomics Laboratory (FSG-Lab: https://fsg-lab.com/) also signed a MoU for a strategic partnership intended to bring T-CURX non-viral CAR-T therapies to Dubai and to the Middle East region.